カテゴリー： LP Information, 世界, 医療/バイオ

甲状腺機能低下症用レボチロキシンナトリウム錠のグローバル市場予測2023-2029

◆英語タイトル：Global Levothyroxine Sodium Tablets for Hypothyroidism Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23OT9055）◆商品コード：LP23OT9055
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年10月
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「甲状腺機能低下症用レボチロキシンナトリウム錠のグローバル市場」は、過去の販売実績から2022年の世界の甲状腺機能低下症用レボチロキシンナトリウム錠の総販売量を検討し、2023年から2029年の予測される甲状腺機能低下症用レボチロキシンナトリウム錠の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の甲状腺機能低下症用レボチロキシンナトリウム錠の市場規模を掲載し、XXX百万米ドル規模の世界の甲状腺機能低下症用レボチロキシンナトリウム錠市場の詳細な分析を提供します。本インサイトレポートは、世界の甲状腺機能低下症用レボチロキシンナトリウム錠業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の甲状腺機能低下症用レボチロキシンナトリウム錠市場における各社の独自のポジションをより深く理解するために、甲状腺機能低下症用レボチロキシンナトリウム錠製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の甲状腺機能低下症用レボチロキシンナトリウム錠市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。甲状腺機能低下症用レボチロキシンナトリウム錠の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。甲状腺機能低下症用レボチロキシンナトリウム錠の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。甲状腺機能低下症用レボチロキシンナトリウム錠のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

甲状腺機能低下症用レボチロキシンナトリウム錠の世界主要メーカーとしては、Abbvie、 Mylan Pharma、 Merck、 Pfizer、 Lannett Company、 IBSA、 Abbott、 BERLIN-CHEMIE、 CHINA ASSOCIATE PHARMACEUTICALなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の甲状腺機能低下症用レボチロキシンナトリウム錠市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では甲状腺機能低下症用レボチロキシンナトリウム錠市場をセグメンテーションし、種類別 (0.1mg以下、0.1mg-0.2mg、0.2mg-0.3mg、その他)、用途別 (病院、薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：0.1mg以下、0.1mg-0.2mg、0.2mg-0.3mg、その他

・用途別区分：病院、薬局

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の甲状腺機能低下症用レボチロキシンナトリウム錠市場の10年間の市場状況・展望は？
・世界および地域別に見た甲状腺機能低下症用レボチロキシンナトリウム錠市場成長の要因は何か？
・甲状腺機能低下症用レボチロキシンナトリウム錠の市場機会はエンドマーケットの規模によってどのように変化するのか？
・甲状腺機能低下症用レボチロキシンナトリウム錠のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：甲状腺機能低下症用レボチロキシンナトリウム錠の年間販売量2018-2029、地域別現状・将来分析
・甲状腺機能低下症用レボチロキシンナトリウム錠の種類別セグメント：0.1mg以下、0.1mg-0.2mg、0.2mg-0.3mg、その他
・甲状腺機能低下症用レボチロキシンナトリウム錠の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・甲状腺機能低下症用レボチロキシンナトリウム錠の用途別セグメント：病院、薬局
・甲状腺機能低下症用レボチロキシンナトリウム錠の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の甲状腺機能低下症用レボチロキシンナトリウム錠市場
・企業別のグローバル甲状腺機能低下症用レボチロキシンナトリウム錠市場データ：2018-2023年の年間販売量、市場シェア
・企業別の甲状腺機能低下症用レボチロキシンナトリウム錠の年間売上：2018-2023年の売上、市場シェア
・企業別の甲状腺機能低下症用レボチロキシンナトリウム錠販売価格
・主要企業の甲状腺機能低下症用レボチロキシンナトリウム錠生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

甲状腺機能低下症用レボチロキシンナトリウム錠の地域別レビュー
・地域別の甲状腺機能低下症用レボチロキシンナトリウム錠市場規模2018-2023：年間販売量、売上
・主要国別の甲状腺機能低下症用レボチロキシンナトリウム錠市場規模2018-2023：年間販売量、売上
・南北アメリカの甲状腺機能低下症用レボチロキシンナトリウム錠販売の成長
・アジア太平洋の甲状腺機能低下症用レボチロキシンナトリウム錠販売の成長
・ヨーロッパの甲状腺機能低下症用レボチロキシンナトリウム錠販売の成長
・中東・アフリカの甲状腺機能低下症用レボチロキシンナトリウム錠販売の成長

南北アメリカ市場
・南北アメリカの国別の甲状腺機能低下症用レボチロキシンナトリウム錠販売量、売上（2018-2023）
・南北アメリカの甲状腺機能低下症用レボチロキシンナトリウム錠の種類別販売量
・南北アメリカの甲状腺機能低下症用レボチロキシンナトリウム錠の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の甲状腺機能低下症用レボチロキシンナトリウム錠販売量、売上（2018-2023）
・アジア太平洋の甲状腺機能低下症用レボチロキシンナトリウム錠の種類別販売量
・アジア太平洋の甲状腺機能低下症用レボチロキシンナトリウム錠の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の甲状腺機能低下症用レボチロキシンナトリウム錠販売量、売上（2018-2023）
・ヨーロッパの甲状腺機能低下症用レボチロキシンナトリウム錠の種類別販売量
・ヨーロッパの甲状腺機能低下症用レボチロキシンナトリウム錠の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の甲状腺機能低下症用レボチロキシンナトリウム錠販売量、売上（2018-2023）
・中東・アフリカの甲状腺機能低下症用レボチロキシンナトリウム錠の種類別販売量
・中東・アフリカの甲状腺機能低下症用レボチロキシンナトリウム錠の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・甲状腺機能低下症用レボチロキシンナトリウム錠の製造コスト構造分析
・甲状腺機能低下症用レボチロキシンナトリウム錠の製造プロセス分析
・甲状腺機能低下症用レボチロキシンナトリウム錠の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・甲状腺機能低下症用レボチロキシンナトリウム錠の主要なグローバル販売業者
・甲状腺機能低下症用レボチロキシンナトリウム錠の主要なグローバル顧客

地域別の甲状腺機能低下症用レボチロキシンナトリウム錠市場予測レビュー
・地域別の甲状腺機能低下症用レボチロキシンナトリウム錠市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・甲状腺機能低下症用レボチロキシンナトリウム錠の種類別市場規模予測
・甲状腺機能低下症用レボチロキシンナトリウム錠の用途別市場規模予測

主要企業分析
Abbvie、 Mylan Pharma、 Merck、 Pfizer、 Lannett Company、 IBSA、 Abbott、 BERLIN-CHEMIE、 CHINA ASSOCIATE PHARMACEUTICAL
・企業情報
・甲状腺機能低下症用レボチロキシンナトリウム錠製品
・甲状腺機能低下症用レボチロキシンナトリウム錠販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Levothyroxine Sodium Tablets for Hypothyroidism by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Levothyroxine Sodium Tablets for Hypothyroidism by Country/Region, 2018, 2022 & 2029
2.2 Levothyroxine Sodium Tablets for Hypothyroidism Segment by Type
2.2.1 Below 0.1mg
2.2.2 0.1mg-0.2mg
2.2.3 0.2mg-0.3mg
2.2.4 Others
2.3 Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type
2.3.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Type (2018-2023)
2.3.2 Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue and Market Share by Type (2018-2023)
2.3.3 Global Levothyroxine Sodium Tablets for Hypothyroidism Sale Price by Type (2018-2023)
2.4 Levothyroxine Sodium Tablets for Hypothyroidism Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application
2.5.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Sale Market Share by Application (2018-2023)
2.5.2 Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue and Market Share by Application (2018-2023)
2.5.3 Global Levothyroxine Sodium Tablets for Hypothyroidism Sale Price by Application (2018-2023)
3 Global Levothyroxine Sodium Tablets for Hypothyroidism by Company
3.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Breakdown Data by Company
3.1.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Annual Sales by Company (2018-2023)
3.1.2 Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Company (2018-2023)
3.2 Global Levothyroxine Sodium Tablets for Hypothyroidism Annual Revenue by Company (2018-2023)
3.2.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Company (2018-2023)
3.2.2 Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Company (2018-2023)
3.3 Global Levothyroxine Sodium Tablets for Hypothyroidism Sale Price by Company
3.4 Key Manufacturers Levothyroxine Sodium Tablets for Hypothyroidism Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Levothyroxine Sodium Tablets for Hypothyroidism Product Location Distribution
3.4.2 Players Levothyroxine Sodium Tablets for Hypothyroidism Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Levothyroxine Sodium Tablets for Hypothyroidism by Geographic Region
4.1 World Historic Levothyroxine Sodium Tablets for Hypothyroidism Market Size by Geographic Region (2018-2023)
4.1.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Levothyroxine Sodium Tablets for Hypothyroidism Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Levothyroxine Sodium Tablets for Hypothyroidism Market Size by Country/Region (2018-2023)
4.2.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Annual Sales by Country/Region (2018-2023)
4.2.2 Global Levothyroxine Sodium Tablets for Hypothyroidism Annual Revenue by Country/Region (2018-2023)
4.3 Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales Growth
4.4 APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales Growth
4.5 Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales Growth
4.6 Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales Growth
5 Americas
5.1 Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales by Country
5.1.1 Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales by Country (2018-2023)
5.1.2 Americas Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Country (2018-2023)
5.2 Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type
5.3 Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales by Region
6.1.1 APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales by Region (2018-2023)
6.1.2 APAC Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Region (2018-2023)
6.2 APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type
6.3 APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Levothyroxine Sodium Tablets for Hypothyroidism by Country
7.1.1 Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales by Country (2018-2023)
7.1.2 Europe Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Country (2018-2023)
7.2 Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type
7.3 Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism by Country
8.1.1 Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales by Country (2018-2023)
8.1.2 Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Country (2018-2023)
8.2 Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type
8.3 Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Levothyroxine Sodium Tablets for Hypothyroidism
10.3 Manufacturing Process Analysis of Levothyroxine Sodium Tablets for Hypothyroidism
10.4 Industry Chain Structure of Levothyroxine Sodium Tablets for Hypothyroidism
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Levothyroxine Sodium Tablets for Hypothyroidism Distributors
11.3 Levothyroxine Sodium Tablets for Hypothyroidism Customer
12 World Forecast Review for Levothyroxine Sodium Tablets for Hypothyroidism by Geographic Region
12.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Market Size Forecast by Region
12.1.1 Global Levothyroxine Sodium Tablets for Hypothyroidism Forecast by Region (2024-2029)
12.1.2 Global Levothyroxine Sodium Tablets for Hypothyroidism Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Levothyroxine Sodium Tablets for Hypothyroidism Forecast by Type
12.7 Global Levothyroxine Sodium Tablets for Hypothyroidism Forecast by Application
13 Key Players Analysis
13.1 Abbvie
13.1.1 Abbvie Company Information
13.1.2 Abbvie Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.1.3 Abbvie Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbvie Main Business Overview
13.1.5 Abbvie Latest Developments
13.2 Mylan Pharma
13.2.1 Mylan Pharma Company Information
13.2.2 Mylan Pharma Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.2.3 Mylan Pharma Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Pharma Main Business Overview
13.2.5 Mylan Pharma Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.3.3 Merck Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.4.3 Pfizer Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Lannett Company
13.5.1 Lannett Company Company Information
13.5.2 Lannett Company Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.5.3 Lannett Company Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lannett Company Main Business Overview
13.5.5 Lannett Company Latest Developments
13.6 IBSA
13.6.1 IBSA Company Information
13.6.2 IBSA Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.6.3 IBSA Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 IBSA Main Business Overview
13.6.5 IBSA Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.7.3 Abbott Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 BERLIN-CHEMIE
13.8.1 BERLIN-CHEMIE Company Information
13.8.2 BERLIN-CHEMIE Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.8.3 BERLIN-CHEMIE Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BERLIN-CHEMIE Main Business Overview
13.8.5 BERLIN-CHEMIE Latest Developments
13.9 CHINA ASSOCIATE PHARMACEUTICAL
13.9.1 CHINA ASSOCIATE PHARMACEUTICAL Company Information
13.9.2 CHINA ASSOCIATE PHARMACEUTICAL Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
13.9.3 CHINA ASSOCIATE PHARMACEUTICAL Levothyroxine Sodium Tablets for Hypothyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 CHINA ASSOCIATE PHARMACEUTICAL Main Business Overview
13.9.5 CHINA ASSOCIATE PHARMACEUTICAL Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Levothyroxine Sodium Tablets for Hypothyroidism Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Levothyroxine Sodium Tablets for Hypothyroidism Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Below 0.1mg
Table 4. Major Players of 0.1mg-0.2mg
Table 5. Major Players of 0.2mg-0.3mg
Table 6. Major Players of Others
Table 7. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type (2018-2023) & (K Pcs)
Table 8. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Type (2018-2023)
Table 9. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Type (2018-2023) & ($ million)
Table 10. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Type (2018-2023)
Table 11. Global Levothyroxine Sodium Tablets for Hypothyroidism Sale Price by Type (2018-2023) & (US$/Pcs)
Table 12. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application (2018-2023) & (K Pcs)
Table 13. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Application (2018-2023)
Table 14. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Application (2018-2023)
Table 15. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Application (2018-2023)
Table 16. Global Levothyroxine Sodium Tablets for Hypothyroidism Sale Price by Application (2018-2023) & (US$/Pcs)
Table 17. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales by Company (2018-2023) & (K Pcs)
Table 18. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Company (2018-2023)
Table 19. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Company (2018-2023)
Table 21. Global Levothyroxine Sodium Tablets for Hypothyroidism Sale Price by Company (2018-2023) & (US$/Pcs)
Table 22. Key Manufacturers Levothyroxine Sodium Tablets for Hypothyroidism Producing Area Distribution and Sales Area
Table 23. Players Levothyroxine Sodium Tablets for Hypothyroidism Products Offered
Table 24. Levothyroxine Sodium Tablets for Hypothyroidism Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales by Geographic Region (2018-2023) & (K Pcs)
Table 28. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share Geographic Region (2018-2023)
Table 29. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales by Country/Region (2018-2023) & (K Pcs)
Table 32. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Country/Region (2018-2023)
Table 33. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales by Country (2018-2023) & (K Pcs)
Table 36. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Country (2018-2023)
Table 37. Americas Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Country (2018-2023)
Table 39. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type (2018-2023) & (K Pcs)
Table 40. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application (2018-2023) & (K Pcs)
Table 41. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales by Region (2018-2023) & (K Pcs)
Table 42. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Region (2018-2023)
Table 43. APAC Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Region (2018-2023)
Table 45. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type (2018-2023) & (K Pcs)
Table 46. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application (2018-2023) & (K Pcs)
Table 47. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales by Country (2018-2023) & (K Pcs)
Table 48. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Country (2018-2023)
Table 49. Europe Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Country (2018-2023)
Table 51. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type (2018-2023) & (K Pcs)
Table 52. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application (2018-2023) & (K Pcs)
Table 53. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales by Country (2018-2023) & (K Pcs)
Table 54. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales by Type (2018-2023) & (K Pcs)
Table 58. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales by Application (2018-2023) & (K Pcs)
Table 59. Key Market Drivers & Growth Opportunities of Levothyroxine Sodium Tablets for Hypothyroidism
Table 60. Key Market Challenges & Risks of Levothyroxine Sodium Tablets for Hypothyroidism
Table 61. Key Industry Trends of Levothyroxine Sodium Tablets for Hypothyroidism
Table 62. Levothyroxine Sodium Tablets for Hypothyroidism Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Levothyroxine Sodium Tablets for Hypothyroidism Distributors List
Table 65. Levothyroxine Sodium Tablets for Hypothyroidism Customer List
Table 66. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Forecast by Region (2024-2029) & (K Pcs)
Table 67. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales Forecast by Country (2024-2029) & (K Pcs)
Table 69. Americas Levothyroxine Sodium Tablets for Hypothyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales Forecast by Region (2024-2029) & (K Pcs)
Table 71. APAC Levothyroxine Sodium Tablets for Hypothyroidism Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Europe Levothyroxine Sodium Tablets for Hypothyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales Forecast by Country (2024-2029) & (K Pcs)
Table 75. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Forecast by Type (2024-2029) & (K Pcs)
Table 77. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Forecast by Application (2024-2029) & (K Pcs)
Table 79. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Abbvie Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 81. Abbvie Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 82. Abbvie Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 83. Abbvie Main Business
Table 84. Abbvie Latest Developments
Table 85. Mylan Pharma Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 86. Mylan Pharma Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 87. Mylan Pharma Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 88. Mylan Pharma Main Business
Table 89. Mylan Pharma Latest Developments
Table 90. Merck Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 92. Merck Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 97. Pfizer Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Lannett Company Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 101. Lannett Company Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 102. Lannett Company Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 103. Lannett Company Main Business
Table 104. Lannett Company Latest Developments
Table 105. IBSA Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 106. IBSA Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 107. IBSA Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 108. IBSA Main Business
Table 109. IBSA Latest Developments
Table 110. Abbott Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 111. Abbott Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 112. Abbott Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 113. Abbott Main Business
Table 114. Abbott Latest Developments
Table 115. BERLIN-CHEMIE Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 116. BERLIN-CHEMIE Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 117. BERLIN-CHEMIE Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 118. BERLIN-CHEMIE Main Business
Table 119. BERLIN-CHEMIE Latest Developments
Table 120. CHINA ASSOCIATE PHARMACEUTICAL Basic Information, Levothyroxine Sodium Tablets for Hypothyroidism Manufacturing Base, Sales Area and Its Competitors
Table 121. CHINA ASSOCIATE PHARMACEUTICAL Levothyroxine Sodium Tablets for Hypothyroidism Product Portfolios and Specifications
Table 122. CHINA ASSOCIATE PHARMACEUTICAL Levothyroxine Sodium Tablets for Hypothyroidism Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 123. CHINA ASSOCIATE PHARMACEUTICAL Main Business
Table 124. CHINA ASSOCIATE PHARMACEUTICAL Latest Developments
List of Figures
Figure 1. Picture of Levothyroxine Sodium Tablets for Hypothyroidism
Figure 2. Levothyroxine Sodium Tablets for Hypothyroidism Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Levothyroxine Sodium Tablets for Hypothyroidism Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Below 0.1mg
Figure 10. Product Picture of 0.1mg-0.2mg
Figure 11. Product Picture of 0.2mg-0.3mg
Figure 12. Product Picture of Others
Figure 13. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Type in 2022
Figure 14. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Type (2018-2023)
Figure 15. Levothyroxine Sodium Tablets for Hypothyroidism Consumed in Hospital
Figure 16. Global Levothyroxine Sodium Tablets for Hypothyroidism Market: Hospital (2018-2023) & (K Pcs)
Figure 17. Levothyroxine Sodium Tablets for Hypothyroidism Consumed in Pharmacy
Figure 18. Global Levothyroxine Sodium Tablets for Hypothyroidism Market: Pharmacy (2018-2023) & (K Pcs)
Figure 19. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Application (2022)
Figure 20. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Application in 2022
Figure 21. Levothyroxine Sodium Tablets for Hypothyroidism Sales Market by Company in 2022 (K Pcs)
Figure 22. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Company in 2022
Figure 23. Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Company in 2022
Figure 25. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales 2018-2023 (K Pcs)
Figure 28. Americas Levothyroxine Sodium Tablets for Hypothyroidism Revenue 2018-2023 ($ Millions)
Figure 29. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales 2018-2023 (K Pcs)
Figure 30. APAC Levothyroxine Sodium Tablets for Hypothyroidism Revenue 2018-2023 ($ Millions)
Figure 31. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales 2018-2023 (K Pcs)
Figure 32. Europe Levothyroxine Sodium Tablets for Hypothyroidism Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales 2018-2023 (K Pcs)
Figure 34. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Revenue 2018-2023 ($ Millions)
Figure 35. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Country in 2022
Figure 36. Americas Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Country in 2022
Figure 37. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Type (2018-2023)
Figure 38. Americas Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Application (2018-2023)
Figure 39. United States Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Region in 2022
Figure 44. APAC Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Regions in 2022
Figure 45. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Type (2018-2023)
Figure 46. APAC Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Application (2018-2023)
Figure 47. China Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Country in 2022
Figure 55. Europe Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Country in 2022
Figure 56. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Type (2018-2023)
Figure 57. Europe Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Application (2018-2023)
Figure 58. Germany Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share by Application (2018-2023)
Figure 67. Egypt Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Levothyroxine Sodium Tablets for Hypothyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Levothyroxine Sodium Tablets for Hypothyroidism in 2022
Figure 73. Manufacturing Process Analysis of Levothyroxine Sodium Tablets for Hypothyroidism
Figure 74. Industry Chain Structure of Levothyroxine Sodium Tablets for Hypothyroidism
Figure 75. Channels of Distribution
Figure 76. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Forecast by Region (2024-2029)
Figure 77. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Levothyroxine Sodium Tablets for Hypothyroidism Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Levothyroxine Sodium Tablets for Hypothyroidism Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 甲状腺機能低下症用レボチロキシンナトリウム錠のグローバル市場予測2023-2029(Global Levothyroxine Sodium Tablets for Hypothyroidism Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • レボチロキシンナトリウム錠のグローバル市場予測2023-2029
  • レボチロキシンナトリウム注射のグローバル市場予測2023-2029
  • 経口レボチロキシンナトリウムの世界市場見通し2023年-2029年
  • 世界のレボチロキシンナトリウム市場2024

    • ◆H&Iグローバルリサーチのお客様（例）◆